4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biohaven Ltd. (BHVN) operates in the Biotechnology industry and is headquartered in New Haven, United States with about 274 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, BHVN reported $0M in revenue and ($739M) in net income.
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($745M) | ($885M) | ($436M) | ($568M) | — |
| Net Income | ($739M) | ($846M) | ($408M) | ($570M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($130M) | ($143M) | ($169M) | ($212M) | ($222M) |
| Net Income | ($130M) | ($146M) | ($173M) | ($198M) | ($222M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $451M | $615M | $513M | $662M | — |
| Total Liabilities | $399M | $192M | $85M | $123M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BHVN viewer.
About TickerBase · Data methodology & sources